In this third part of our review of skin problems seen in critically ill patients, we focus on a number of life-threatening systemic disorders in which cutaneous findings are prominent. We discuss purpura fulminans, toxic shock syndrome, systemic lupus erythematosus, acquired immunodeficiency syndrome, Lyme disease, graft-versus-host disease, and Rocky Mountain spotted fever.
Get full access to this article
View all access options for this article.
References
1.
Spicer TE, Rau JMPurpura fulminans. Am J Med1976;61:566-571
Marciniak E. , Wilson HD, Marlar RANeonatal purpura fulminans: a genetic disorder related to the absence of protein C in the blood. Blood1985;65: 15-20
4.
Targan SR, Chassin MRG, Guz LBDilantin-induced disseminated intravascular coagulation with purpura fulminans . Ann Intern Med1975;83:227-230
5.
Feinstein DIDiagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. Blood1982;60:284-287
6.
Chu DZJ , Blaisdell FWPurpura fulminans. Am J Surg1982;143:356-362
7.
Branson HE, Katz J.A structured approach to the management of purpura fulminans. J Natl Med Assoc1983;75:821-825
8.
Garbe PL, Arko RJ, Reingold AL, et al. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins. JAMA1985;253:2538-2542
9.
Hanna BA, Tierno PM Jr.Toxic shock syndrome toxin. JAMA1985 ;254:2062
10.
Wager GPToxic shock syndrome: a review. Am J Obstet Gynecol1983;146:93-102
11.
Center for Disease Control.Toxic-shock syndrome, United States, 1970-1982. MMWR1982;31:201-204
12.
Reingold ALNonmenstrual toxic shock syndrome: the growing picture. JAMA1983;249:932
13.
Buchdahl R. , Levin M., Wilkins B., et al. Toxic shock syndrome. Arch Dis Child1985;60:563-567
14.
Bartlett P., Reingold AL, Graham DR, et al. Toxic shock syndrome associated with surgical wound infections . JAMA1982;247:1448-1450
15.
Findlay RF, Odom RBToxic shock syndrome. Int J Dermatol1982;21:117-121
16.
Bach MCDermatologic signs in toxic shock syndrome-clues to diagnosis. J Am Acad Dermatol1983;8:343-347
17.
Tuffanelli DLLupus erythematosus. J Am Acad Dermatol1981;4:127-142
18.
Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982;25:1271-1277
19.
Gilliam JN, Sontheimer RDDistinctive cutaneous subsets in the spectrum of lupus erythematosus . J Am Acad Dermatol1981;4:471-475
Camisa C., Sharma HMVesiculobullous systemic lupus erythematosus. Report of two cases and a review of the literature. J Am Acad Dermatol1983 ;9: 924-933
22.
Provost TT, Andres G., Maddison PJ, et al. Lupus band test in untreated SLE patients: correlation of immunoglobulin deposition in the skin of extensor forearm with clinical renal disease and serologic abnormalities. J Invest Dermatol1980;74:407-412
23.
Connolly SMManagement of the cutaneous manifestations of lupus erythematosus. Semin Dermatol1985 ;4:82-89
24.
Hatcher VAMucocutaneous infections in acquired immune deficiency syndrome. In: Friedman-Kien AE, Laubenstein LJ, eds. AIDS: the epidemic of Kaposi's sarcoma and opportunistic infections. New York: Masson, 1984:245-252
25.
Mathes BM, Douglass MCSeborrheic dermatitis in patients with acquired immunodeficiency syndrome . J Am Acad Dermatol1985;13:947-951
26.
Fauci AS, Masur H., Gelmann EP, et al. The acquired immunodeficiency syndrome: an update. Ann Intern Med1985;102:800-813
27.
Moskowitz LB , Hensley GT, Gould EW, et al. Frequency and anatomic distribution of lymphadenopathic Kaposi's sarcoma in the acquired immunodeficiency syndrome: an autopsy series. Hum Pathol1985;116:447-456
Volberding PA, Abrams DI, Conant M., et al. Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med1985;103:335-338
30.
Mintzer DM, Real FX, Jovino L., et al. Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome. Ann Intern Med1985;102: 200-202
31.
Croxson TS, Ebanks D., Mildvan D.Atypical mycobacteria and Kaposi's sarcoma in the same biopsy specimens . N Engl J Med1983;308:1476
32.
Lind SE, Gross PL, Andiman WA, et al. Malignant lymphoma presenting as Kaposi's sarcoma in a homosexual man with the acquired immunodeficiency syndrome. Ann Intern Med1985;102:338-340
33.
Burkes RL, Gal AA, Stewart ML, et al. Simultaneous occurrence of Pneumocystic carinii pneumonia, cytomegalovirus infection, Kaposi's sarcoma, and B-immunoblastic sarcoma in a homosexual man . JAMA1985;253:3425-3428
34.
Mitsuyasu R. , Groopman J., Volberding P.Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi's sarcoma. N Engl J Med1983;308:1535-1536
35.
Eisenstat BA , Wormser GPSeborrheic dermatitis and butterfly rash in AIDS. N Engl J Med1984; 311:189
36.
Arndt KA, Jick H.Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program. JAMA1976;235:918-922
37.
Johnson TN, Duvic M., Rapini RP, et al. AIDS exacerbates psoriasis. N Engl J Med1985;313:1415
38.
Borton LK, Wintroub BUDisseminated cryptococcosis presenting as herpetiform lesions in a homosexual man with acquired immunodeficiency syndrome. J Am Acad Dermatol1984;10:387-390
39.
Hazelhurst JA, Vismar HFHistoplasmosis presenting with unusual skin lesions in acquired immunodeficiency syndrome (AIDS). Br J Dermatol1985; 113:345-348
40.
Siegel FP, Lopez C., Hammer GS, et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med1981;305:1439-1444
41.
Lombardo PCMolluscum contagiosum and the acquired immunodeficiency syndrome. Arch Dermatol1985;121:834-835
42.
Redfield RR , James WD, Wright DC, et al. Severe molluscum contagiosum infection in a patient with human T cell lymphotrophic (HTLV-III) disease. J Am Acad Dermatol1985;13:821-824
43.
Gottlieb MS , Groopman JE, Weinstein WM, et al. The acquired immunodeficiency syndrome . Ann Intern Med1983;99:208-220
44.
Steere ACLyme arthritis: a new clinical entity. Hosp Pract1978;13:143
45.
Burgdorfer W. , Barbour AG, Hayes SF, et al. Lyme disease-a tick-borne spirochetosis? Science1982; 216:1317
46.
Gunby P.Lyme disease: spirochetes up to old ticks? JAMA1982;248:812
47.
Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med1983;308:733
48.
Benache JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med1983;308:740
49.
Center for Disease Control.Update: Lyme disease- United States. MMWR1984;33:268
50.
Schmid GP, Horsley R., Steere AC, et al. Surveillance of Lyme disease in the United States, 1982. J Infect Dis1985;151:1144-1149
51.
Gerster JC, Guggi S., Perroud H., et al. Lyme arthritis appearing outside the United States: a case report from Switzerland. Br Med J1981;283:951
52.
Editor: update: Lyme disease and cases occurring during pregnancy . JAMA1985;254:736-741
53.
Fisher M., Trusky DEErythema chronicum migrans and Lyme arthritis. In Moschella SL, ed. Dermatology update. New York: Elsevier, 1982:75
54.
Schulze TL, Bowen GS, Bosler EM, et al. Amblyomma americanum: a potential vector of Lyme disease in New Jersey. Science984;224:601-603
55.
Steere AC, Malawista SECases of Lyme disease in the United States: locations correlated with distribution of Ixodes dammini. Ann Intern Med1979;91: 730
56.
Schrock CGLyme disease: additional evidence of widespread distribution. Am J Med1982;72:700
57.
Williams DN , Vance JC, Hedberg C., et al. Lyme disease and erythema chronicum migrans in Minnesota. Minn Med1982;65:217
58.
Dryer RF, Goellner PG, Carney ASLyme arthritis in Wisconsin. JAMA1979;241:498
59.
Johnston YE , Duray PH, Steere AC, et al. Lyme arthritis: spirochetes found in synovial microangiopathic lesions. Am J Pathol1985;118:26-34
60.
Hyde FW, Johnson RCGenetic relationship of Lyme disease spirochetes to Borrelia, Treponema and Leptospira spp. J Clin Microbiol1984;20:151-154
61.
Schmid GP, Steigerwalt NG, Johnson SE, et al. DNA characterization of the spirochete that causes Lyme disease . J Clin Microbiol1984;20:155-158
62.
Berger BWErythema chronicum migrans of Lyme disease. Arch Dermatol1984;120:1017-1021
63.
Steere AC, Malawista SE, Bartenhagen NHThe clinical spectrum and treatment of Lyme disease. Yale J Biol Med1984;57:453-461
64.
Steere AC, Gibofsky A., Patarroyo ME, et al. Chronic Lyme arthritis: clinical and immunogenetic differentiation from rheumatoid arthritis. Ann Intern Med1979;90:896
65.
Steere AC, Malawista SE, Hardin JA, et al. Erythema chronicum migrans and Lyme arthritis: the enlarging clinical spectrum. Ann Intern Med1977;86: 685
66.
Schlesinger PA, Duray PH, Burke BAMaternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med1985;103:67-68
67.
Reik L., Steere AC, Bartenhagen NH, et al. Neurologic abnormalities of Lyme disease. Medicine1979; 58:281
68.
Steere AC, Hutchinson GJ, Rahn DW, et al. Treatment of the early manifestations of Lyme disease. Ann Intern Med1983;99:22
69.
Pachner AR, Steere ACThe triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology1985;35: 47-53
70.
Steere AC, Batsford WP, Weinberg M., et al. Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med1980;93:8
71.
Steere AC, Hardin JA, Ruddy S., et al. Lyme arthritis: correlation of serum and cryoglobulin IgM with activiry, and serum IgG with remission. Arthritis Rheum1979:22:471
72.
Steere AC, Hardin JA, Malawista SE: Erythema chronicum migrans and Lyme arthritis: serum cryoprecipitates associated with clinical activity of skin and joints. Science1977;196:1121
73.
Mertz LE, Nobig GH, Duffy J., et al. Ticks, spirochetes, and new diagnostic tests for Lyme disease . Mayo Clin Proc1985;60:402-406
74.
Craft JE, Grodzicki RL, Steere ACAntibody response in Lyme Disease: evaluation of diagnostic tests . J Infect Dis1984;149:789-795
75.
Russell H., Sampson JS, Schmid GP, et al. Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease. J Infect Dis1984;149:465-470
76.
Hardin JA, Steere AC, Malawista SE: Immune complexes and the evolution of Lyme arthritis: dissemination and localization of abnormal Clq binding activity. N Engl J Med1979;301:1358
77.
Steere AC, Green J., Schoen RTSuccessful parenteral penicillin therapy of established Lyme arthritis . N Engl J Med1985;312:869-874
78.
Steere AC, Malawista SE, Newman JH, et al. Antibiotic therapy in Lyme disease. Ann Intern Med1980; 93:1
79.
Steere AC, Pachner AR, Malawista SENeurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann Intern Med1983 ;99:767
80.
James WD, Odom RBGraft-v-host disease. Arch Dermatol1983;119:683
81.
Neudorf S., Filipovich A., Ramsey N., et al. Prevention and treatment of acute graft-versus-host disease . Seminars Hematol1984;21:91-100
82.
Farmer ER, Hood AFGraft-versus-host disease. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, eds. Update: dermatology in general medicine. New York: McGraw-Hill, 1983:28
83.
Ammann AJNew insights into the causes of immunodeficiency disorders. J Am Acad Dermatol1984; 11:653-660
84.
Peck GL, Herzig GP, Elias PMToxic epidermal necrolysis in a patient with graft-versus-host reaction . Arch Dermatol1972;105:561-569
85.
Grossbard EB , O'Reilly RJBone marrow transplantation in the treatment of leukemia. Clin Bull1980; 10:109
86.
Storb R., Gluckman E., Thomas ED, et al. Treatment of established human graft-versus-host disease by antithymocyte globulin. Blood1974;44:57
87.
Abramowicz M, eds. Cyclosporine-a new immunosuppressive agent. Med Lett Drugs Ther1983; 25:77
88.
Cohen DJ, Loertscher R., Rubin MF, et al. Cyclosporine: a new immunosuppressive agent for organ transplantation . Ann Intern Med1984;101:667-682
89.
Deeg HJ, Storb R.Graft-versus-host disease: pathophysiological and clinical aspects . Annu Rev Med1984;35:11-24
90.
Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med1980 ;69:204-217
91.
Barrett AP, Bilous AMOral patterns of acute and chronic graft-vs-host disease. Arch Dermatol1984; 120:1461-1465
92.
Lawley TJ, Peck GL, Moutsopoulos HMScleroderma, Sjögren-like syndrome, and chronic graft-v-host disease . Ann Intern Med1977;87:707
93.
Gratwhol AA , Moutsopoulos HM, Chused TM, et al. Sjögren-type syndrome after allogeneic bone marrow transplantation. Ann Intern Med1977;87:703-706
94.
Fishbein DD , Kaplan JE, Bernard KW, et al. Surveillance of Rocky Mountain spotted fever in the United States, 1981-1983. J Infect Dis1984;150:609-611
95.
Rocky Mountain spotted fever, United States , 1984. MMWR1985;34:195-197
96.
D'Angelo LJ , Winkler WG, Bregman DJRocky Mountain spotted fever in the United States, 1975-1977. J Infect Dis1978;138:273-276
Kelsey DSRocky Mountain spotted fever. Pediatr Clin North Am1979;26:367-376
99.
Burnett JWRickettsiosis: a review for the dermatologist. J Am Acad Dermatol1980;2:359-373
100.
Schaffner W.Rickettsioses. In: Fitzpatrick TD, Eisen AZ, Wolff K , et al, eds. Dermatology in general medicine. New York: McGraw-Hill , 1979:1563-1570
101.
Woodward TERocky Mountain spotted fever: epidemiological and early clinical signs and keys to treatment and reduced mortality. J Infect Dis1984; 150:465-467
102.
Helmick CG , Bernard KW, D'Angelo LJRocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis1984;150:480-488
103.
Ramsey PG, Press OWSuccessful treatment of Rocky Mountain spotted fever. West J Med1984;140: 94-96
104.
Katz DA, Dworzack DL, Horowitz EA, et al. Encephalitis associated with Rocky Mountain spotted fever. Arch Pathol Lab Med1985;109:771-773
105.
Ramphal R. , Kluge R., Cohen V., et al. Rocky Mountain spotted fever and jaundice . Arch Intern Med1978; 138:260-263
106.
Randall MB , Walker DHRocky Mountain spotted fever, gastrointestinal and pancreatic lesions and rickettsial infections. Arch Pathol Lab Med1984;108: 963-967
107.
Helmick CG, Winkler WGEpidemiology of Rocky Mountain spotted fever 1975-1979. In: Burgdorfer W, Anacker RL , eds. Rickettsiae and rickettsial diseases. New York: Academic Press, 1981:547-557
108.
Hays PLRocky Mountain spotted fever in children in Kansas: the diagnostic value of IgM-specific immunofluorescence assay. J Infect Dis1985;151:369-370
109.
Walker DH, Cain BG, Olmstead TMLaboratory diagnosis of Rocky Mountain spotted fever by immunofluorescent demonstration of Rickettsiae rickettsii in cutaneous lesions. Am J Clin Pathol1978;69:619-623
110.
Goodman JSRocky Mountain spotted fever. In: Provost PT, Farmer ER, eds. Current therapy in dermatology 1985-1986. Philadelphia : BC Decker, 1985:214-217
